(Q54076013)

24 May 2018

title

The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. (English)

1 reference

24 May 2018

author name string

Rich S

series ordinal

1

1 reference

24 May 2018

McLaughlin VV

series ordinal

2

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

24 May 2018

Journal of the American College of Cardiology

published in

1 reference

24 May 2018

volume

34

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

1184-1187

1 reference

24 May 2018

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Prostacyclin is a circulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Angiotensin II mediates systemic rebound hypertension after cessation of prostacyclin infusion in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

New insights into mechanisms underlying nitrate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Positive inotropic effect of a stable analogue of PGI2 and of PGI2 on isolated guinea pig atria. Mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Cyclic AMP-dependent and independent effects of prostaglandins on the contraction-relaxation cycle of spontaneously beating isolated rat atria

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Catecholamine cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

Converting enzyme inhibition improves congestion and survival in hypertensive rats with high-output heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900320-4

7 January 2021

10.1016/S0735-1097(99)00320-4

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10520810

1 reference

24 May 2018